In March 2019, the World Health Organization (WHO) recognized the COVID-19 pandemic
as a global issue. To reduce the spread of this disease, health safety pathways were …

Low Back Pain (LBP) is currently the first cause of disability in the world, with a significant
socioeconomic burden. Diagnosis and treatment of LBP often involve a multidisciplinary …

This systematic review and meta-analysis aimed to analyze the effects of workplace
interventions (WI) on clinical outcomes related to low back pain (LBP) in a worker …

Chronic low back pain (CLBP) is the most common cause of disability worldwide, affecting
about 12% to 30% of the adult population. Psychological factors play an important role in the …

The aim of this study was to examine the levels of health-related quality of life (HRQoL), pain
intensity, and mental distress in participants with chronic low back pain (CLBP), and to …

Study Design. In vitro study. Objective. To investigate the effect of irisin on human nucleus
pulposus cells (hNPCs) in vitro. Summary of Background Data. Physical exercise (PE) …

Introduction: Intradiscal mesenchymal stromal cell (MSC) therapies for intervertebral disc
degeneration (IDD) have been gaining increasing interest due to their capacity to ameliorate …

Study design Systematic review. Objective To investigate the efficacy of nonsurgical
interventional treatments for chronic low back pain (LBP) caused by facet joint syndrome …

BACKGROUND: Few studies have established the minimum clinically important difference
(MCID) in patients undergoing minimally invasive transforaminal lumbar interbody fusion …

Low back pain (LBP) is one of the most frequent symptoms associated with intervertebral
disc degeneration (IDD) and affects more than 80% of the population, with strong …